← Back to Clinical Trials
Recruiting NCT07121075

NCT07121075 The Effects of a Dynamic Arm Support in Daily Life

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07121075
Status Recruiting
Phase
Sponsor Hasselt University
Condition Neuromuscular Disease
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2024-12-02
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Dynamic arm support

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2024-12-02 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this mixed method study is to learn about how a dynamic arm support device (DAS) helps people with everyday activities. The study focuses on people with neuro(-muscular) conditions, age 16 and older. The research questions that are formulated, are: * How does a person experience their daily activities, with and without a DAS? * What are the contextual (external and personal) factors that influence the use of a DAS? Participants will take part in three testing sessions. In each session, they must complete a few questionnaires and participate in an interview. The first time, without DAS. In the second and third session, they will be using their DAS (resp. 3 to 4 weeks and 3 months). The data collection will be executed by phone, digital questionnaires and/or paper.

Eligibility Criteria

Inclusion Criteria: * Age: 16 and oler * Being able to understand and comprehend test instructions * Using a DAS from Focal Meditech (Balancer, Flowing, Dowing, Gowing 2 or Top Help) Exclusion Criteria: /

Contact & Investigator

Central Contact

Annemie Spooren, Professor Doctor

✉ annemie.spooren@uhasselt.be

📞 +3211 26 81 11

Principal Investigator

Joke Raats, Doctor

PRINCIPAL INVESTIGATOR

UHasselt

Frequently Asked Questions

Who can join the NCT07121075 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, studying Neuromuscular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07121075 currently recruiting?

Yes, NCT07121075 is actively recruiting participants. Contact the research team at annemie.spooren@uhasselt.be for enrollment information.

Where is the NCT07121075 trial being conducted?

This trial is being conducted at Tilburg, Netherlands.

Who is sponsoring the NCT07121075 clinical trial?

NCT07121075 is sponsored by Hasselt University. The principal investigator is Joke Raats, Doctor at UHasselt. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology